the Trump administration and the anti-poverty NGO Oxfam have found themselves making the same big-picture point recently: medicines are too damn expensive. And a key part of the problem is the lack of consistent information about drug pricing.
the Trump administration and the anti-poverty NGO Oxfam have found themselves making the same big-picture point recently: medicines are too damn expensive. And a key part of the problem is the lack of consistent information about drug pricing.